MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercise of
stock options
$5K
Net cash provided by
financing activities
$5K
Net change in cash
and cash...
-$27,329K
Canceled cashflow
$5K
Stock-based compensation
expense
$1,605K
Prepaid expenses and
other current assets
-$929K
Non-cash operating lease
expense
$58K
Depreciation and
amortization expense
$38K
Unrealized foreign
currency transaction...
-$21K
Proceeds from maturities
of marketable...
$31,900K
Net cash used in
operating activities
-$14,379K
Net cash used in
investing activities
-$12,955K
Canceled cashflow
$2,651K
Canceled cashflow
$31,900K
Net loss
-$13,722K
Accrued expenses and
other current...
-$1,532K
Purchases of marketable
securities
$44,855K
Accounts payable
-$1,409K
Accretion of discounts on
marketable securities, net
$305K
Operating lease
liabilities
-$62K
Back
Back
Cash Flow
source: myfinsight.com
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)